The interleukin 2 receptor (IL-2K) is known to be comprised of at least three genetically distinct subunits termed c~, B, and 3/. These chains can be expressed individually or in various combinations resulting in distinct receptors with different affinities for IL-2. In contrast to a and/8, the cell surface expression of the 3' chain protein previously has not been well-characterized. To examine cell surface expresssion of IL-2R3, on hematopoietic cells, we developed two new monoclonal antibodies (mAbs) specific for this protein. Both 1All (immunoglobulin [IgG1]) and 3Gll (IgM) specifically reacted with murine cells transfected with IL-2K3" cDNA, and immunoprecipitation studies indicated that both antibodies precipitated a protein of approximately 62-65 kD. Scatchard analysis of IL-2 binding to murine cells transfected with cDNA-encoding combinations of IL-2R components demonstrated that neither B nor 3, chain bind IL-2 with measurable affinity, but coexpression of both/8 and 3' is sufficient to form an intermediate affinity receptor. In the absence of 3' chain,/8 chain interacts with ot chain to form a "pseudo-high" affinity receptor. In contrast, 3' chain does not appear capable of interacting with a chain in the absence of/8 chain. Thus, 3' chain appears to interact only with/~, but ~ chain is capable of interacting with both ot and 3'. Using the newly developed mAbs to examine cell surface expression by immunofluorescence, resting T cells were found to express low levels of 3' chain without detectable a or/8. Early after mitogen stimulation, T cells expressed higher levels of oe,/~, and 3'. However, at later time points, T cells expressed ot and 3' in marked excess over/8. Thus, formation of high affinity IL-2R on activated T cells was primarily limited by/8 chain expression. In contrast, resting natural killer (NK) cells constitutively expressed IL-2RB without detectable cr or 3'. After activation with either IL-2 or IL-12, expression of both c~ and 3' transiently increased and then returned to very low levels. Expression of functional IL-2R on resting and activated NK cells, therefore, appeared to be primarily limited by the expression of 3' chain. IL-2 binding studies with resting NK cells confirmed the results ofimmunofluorescence studies indicating the presence of very low numbers of intermediate affinity (/~3') receptors for IL-2 on these cells. NK cells obtained from patients receiving IL-2 therapy were phenotypically similar to resting NK cells. These studies have identified marked differences in IL-2R composition in two different types of cytotoxic lymphocytes, further underscoring the complexity of this receptor/ligand system. With new reagents specific for IL-2R3", it will now be possible to examine further the functional significance of these differences.
(CD25, Tac antigen) (9) is a 55-kD protein that binds IL-2 with an equilibrium dissociation constant (Ka) of ~10 riM. IL-2Rol has a very small intracellular domain and does not exhibit homology to other known cytokine receptors. The second IL-2R component, IL-2R3, is a 75-kD protein with a large intracellular segment and areas of well-defined homology to other cytokine receptor superfamily members (10) (11) (12) . IL-2R3 is known to play an important role in receptor-mediated signaling, in part through association with cytoplasmic protein tyrosine kinases (13, 14) . The third and most recently identified IL-2R component, IL-2R 7, is a 64-kD protein that also has structural homology to other cytokine receptors (15, 16) . Like IL-2R3, IL-2R7 by itself has a very low affinity for IL-2 (17) . However, when expressed together, these two chains form an intermediate affnity receptor with a Kd of ",~1 riM. Expression of all three receptor components is required to form a high affinity IL-2 receptor (Kd, "10 pM).
Although each component of the IL-2R complex is likely to play an important role in regulating the cellular response to IL-2, the central role of the 7 chain is supported by the demonstration that X-linked SCID occurs as a direct result of T chain mutations (18, 19) . In addition, recent studies (20) (21) (22) have provided compelling evidence that the IL-2R7 chain is also a component of the receptors for IL-4 and IL-7. Moreover, it is likely that the 3/chain is a common component of additional cytokine receptors. However, in contrast to other IL-2R components, 3/chain mRNA appears to be constitutively expressed in all lymphoid cells. This finding is consistent with the demonstration that the IL-2R 7 promoter sequence is GC-rich and lacks TATA motifs, and suggests that surface expression of 3' chain is likely to be regulated primarily by posttranscriptional mechanisms (15, 23) . However, lack of suitable reagents has previously prevented detailed examination of cell surface expression of IL-2R 7.
In the present studies we developed two new murine mAbs specific for the IL-2R 7 chain. These mAbs have been used to examine IL-2R 7 expression by normal human lymphocytes as well as hematopoietic cell lines. To elucidate the functional consequences of expression of distinct IL-2R subunits, the surface expression of each IL-2R component on resting and activated T and NK cells was determined. T and NK cells are known to respond very differently to IL-2, and these studies provide further insight into the mechanisms whereby a single cytokine can mediate distinct functional activities in different cell types.
Materials and Methods
Construction of Plasmids. A full-length cDNA for human IL-2R7 was isolated by RT-PCR using the following oligonucleotides: 5'-GAAGGCCTTCTGAACACGACAATTCTGACG (artificial StuI site) or GCTCTAGAGCGAAGAGCAAGCGCCAT-GTTG (XbaI) and Y-GCTCTAGAGCCAAATGAAGGGGTG-CTTACA (XbaI) from YT cell line mRNA. An expression vector containing IL-2R7 cDNA (pMT2.UCHL1 +.IL-2RT.CD45) was derived from pMT2.LCA.1 (CD45 O-isoform) (24, 25) , and synthetic oligonucleotides (5'-GCTTCCAAGGATCCGGAAG-3' and 5'-CGCTTCCGGATCCTTGGAAGC-3') by ligating appropriate restriction fragments in frame. The resulting hybrid protein, UCHL1 +.IL-2RT.CD45, contains portions of several proteins in the following order: (a) CD45 leader sequence; (b) CD45 amino acids 1-8 and 202-218; (c) Ib2R 7 amino acids (L1-N232); (d) seven amino acids (RFQGSGS) arising from the synthetic oligonudeotides; and (e) CD45 amino acids 214-1281 (numbering of CD45 and IL-2R7 amino acid residues according to Streuli et al. [26] and Noguchi et al. [23] , respectively).
The expression vector, pSR~2.IL-2R% was generated by inserting fulMength ID2R7 cDNA into the XbaI multilinker site of a slightly modified version of the pSRcr expression vector (27) . Structures ofplasmid constructs were confirmed by restriction mapping and/or by nudeotide sequencing. FuU-length cDNA encoding Ib2Rc~ and IL-2RB, were also introduced into the pSRcr vector at the appropriate restriction enzyme sites, and designated as pSRcc2.1b2Rc~ and pSRc~2.IL-2R~, respectively.
Transfection ofcDNA. The Abelson virus-transformed murine 300-19 pre-B lymphocyte cell line was transfected with various constructs by electroporation with plasmid DNA using the Cell Porator Electroporation System (Bethesda Research Laboratories, Gaithersburg, MD). pMT2.UCHL1 § .IL-2RT.CD45, pSRc~2.Ib 2R7, and pSV2.neoSP (28) constructs were linearized before transfection with SspI, FspI, and PvuI, respectively. Transfected cells were monitored using available anti-CD45 mAbs, UCHL1 (CD45RO) and GAP8.3 (CD45). UCHL1 binds to the NHaterminal region of the 180-kD isoform, whereas GAP8.3 binds to a more COOH-terminal region of CD45. In subsequent experiments, cotransfection or sequential transfections were also performed as described above using various combinations of pSRoe2.Ib2Ra, pSRoe2.IL-2R3, and pSgoe2.IL-2RT, cr and/3 chain expression vectors were linearized with XmmI. pPGK.Hygro (Hygromycin B resistance gene) was used for sequential transfection.
Production of mAb to the Ib2R T Chain. BALB/c mice were immunized with 300-19(UCHLl § transfectant cells expressing human IL-2R 7 and CD45 epitopes. Fusions were carried out as previously described (29) , and hybridoma supernatants were screened by indirect immunofluorescence for binding to 300-19(UCHL1 + .IL-2RT.CD45) and lack of binding to 300-19(LCA.1) transfectants expressing only human CD45 (25, 30) . Based on this screening, two hybridomas, designated 1All (IgG1) and 3Gll (IgM), were selected and subcloned by limiting dilution. These antibodies also react with 300-19(IL-2RT) cells expressing IL-2R7 protein alone (data not shown), confirming that these antibodies react specifically with IL-2R7 rather than with CD45RO or CD45 epitopes.
Immunoprecipitation. The 300-19(Ib2RT) transfectant cells were surface 125I-labeled by the lactoperoxidase method or were metabolically labeled with [3SS]methionine (New England Nuclear, Cambridge, MA). Radiolabeled cells were washed and solubilized in 1 ml lysis buffer (1% NP-40, 50 mM Tris, pH 8.15, 150 mM NaC1, 1 mM EDTA, I mM PMSF, 2/xg/ml PepstatinA, 10/zg/ml leupeptin, and 10 #g/ml aprotinin). Lysates were preincubated with rabbit anti-mouse Ig (RoeM)-coupled protein A beads, followed by incubation overnight with specific antibodies and RoeM-coupled protein A beads. Immunoprecipitates were washed extensively, followed by addition of sample buffer (60 mM Tris, pH 6.8, 5% 3-MER, and 2% SDS) and subsequently subjected to SDS-PAGE (7.5% gel).
Cell Lines and lsolation of Normal Lymphocytes. T cell lines MT1, Jurkat, Molt4, H9, HPB-ALL, and Rex; B cell lines Daudi, SKW6.4, Nalm6, and CESS; NK cell lines NK3.3, YT-N17, and YT-2C2; myeloid cell lines K562, HL60, U937, KG1, TF1, and Mo7; colon cancer cell line Colo205; cervical cancer cell line HeLa; small cell lung carcinoma cell line SW2; and melanoma cell line SKMEL were maintained in RPMI 1640 with 10% FBS. NK3.3 cells (31) were supplemented with 5-10% leukocyte-conditioned medium (LCM). TF1 and Mo7 were supplemented with 10 ng/ml GM-CSF or 20 ng/ml IIr The preparation of LCM was described previously (32) .
PBMC were isolated on Ficoll-diatrizoate gradients from heparinized blood or from cytophoresis buffy coat cells obtained from normal volunteer donors. Adherent mononuclear cells were depleted by incubation on plastic petri dishes for 1 h at 37~ Enriched NK cells were obtained by incubating PBL with a mixture of T1 (CD5), B1 (CD20), and My4 (CD14) mAb, and then separating antibody-bound cells using immunomagnetic beads (Advanced Magnetics, Inc., Cambridge, MA). In some experiments, enriched NK cells cultured in medium with 100 U/ml I1.-2 or PBL cultured in medium with 1 /xg/ml PHA were used for immunofluorescence experiments. PBMC obtained from patients receiving prolonged treatment with low dose rlL-2 (Amgen, Thousand Oaks, CA) were also examined (33, 34) . Chronic administration of low dose II.-2 by either continuous i.v. infusion or daily subcutaneous injection has previously been shown to expand the total number of circulating NK cells and increase cytolytic activity against both NK-sensitive and -resistant target cells.
mAbs. FITC-or PE-conjugated murine mAbs were obtained from Coulter Immunology (Hialeah, FL), including T3 (CD3, IgG1), NKH1 (CD56, IgG1), IL-2Pd (CD25, IgG2a), B4 (CD19, IgG1), Mo2 (CD14, IgM), and isotype-matched control mAbs. T1 (CD5, IgG2a), B1 (CD20, IgG2a), My4 (CD14, IgG2b), N901 (CD56, IgG1), 3B8 (CD56, IgM), RW2 (CD3, IgG1), 2ad2 (CD3, IgM), UCHL1 (CD45RO), and GAP8.3 (CD45) were used as dilutions of ascites. Purified routine mAbs (FITC conjugated or unconjugated) directed against the p75 subunit (IL-2RB) (35) were kindly provided by Coulter Immunology. Purified 1All (IgG1) and 3Gli (IgM) antibodies were isolated from ascites by affinity chromatography on an Affi-Gel Protein A MAPS II Kit (Bio-Rad, Hercules, CA) or Immunopure IgM Purification Kit (Pierce, Rockford, IL), and were dialyzed against PBS.
Immunofluorescence Analysis. Samples of cells were stained directly or indirectly with FITC-or PE-conjugated mAb, washed, fixed in 1% formaldehyde, and analyzed by flow cytometry as described previously (36) . Goat anti-mouse IgM-FITC (Southern Biotechnology Associates, Birmingham, AL) was used as secondary antibody for staining of 3Gll (IgM). NK3.3 and 1I.-2 activated NK ceUs were stained after the incubation in IL-2-free medium for 2 h at 37~
RT-PCR and Hybridization. RT-PCtk and hybridization were performed as described elsewhere (37, 38) . Primers specific for IL-2K')" were the same as described above. Primers specific for /32-microglobulin were: (nucleotide 1543) 5'-ACCCCCACTGAA-AAAGATGA and (nucleotide 3317) 3'-ATCTTCAAACCTCCA-TGATG. 3,-[32p]ATP-labeled oligomer probes, IL-2R? 5'-TCACAT-CCCTCTTATTCCTGC-3', and B2-microglobulin, 5'-GCCCAA-GATAGTTAAGTGGG-3', were used for hybridization.
~2sI-IL2 Binding Assay. The 12SI-labeled IL-2 was obtained from New England Nuclear or made in one of our laboratories (T. L. Ciardelli) and had a sp act of 1.2-1.5 x 106 or 1.3-1.8 x 106 dpm/pmol, respectively. II.-2 binding was analyzed by scatchard plot (39) . Briefly, cells (1-3 x 1@ cells per aliquot) were incubated at 4~ for 120 min with 125I-IL-2 at serial dilutions ranging from 1 pM to 64 nM in binding medium containing 1% BSA, 0.1% sodium azide, and 25 mM Hepes in RPMI 1640 medium, pH 7.4, in the presence or absence of a 500-fold excess of unlabeled rlL-2. The inhibitory effects of p75 (Ib2R~ antibody), and 1All and 3Gll (IL-2R3, antibodies) on 1I.-2 binding were also examined in the presence of excess amount of antibodies (50/xg/ml).
Results

Immunoprecipitation of Antigens Identified by Anti-IL-2Rg/ mAb.
To confirm the specificity of the newly generated mAb, immunoprecipitations were performed using 300-19(IL-2R'y) transfectant ceils. 1All and 3Gll precipitate a protein of ~62-65 kD from lysates of cells surface labeled with 125I ( Fig. 1 A) or metabolically labeled with [35S]methionine (Fig. 1 B) . Immunoprecipitation of surface-labeled transfectants also revealed an intense band at ~90 kD (see Fig. 3 A). This 90-kD band is also identified in immunoprecipitates of 125I-labeled YT cells (data not shown). This protein does not appear to be either p75 or p55, but has not yet been further characterized. 
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Cell Lines. Table 1 Table 1) . Fig. 4 , almost no ~ or B chain was detectable by flow cytometry on resting T cells, but 3' chain was present at low levels. After PHA stimulation (48 h), surface expression of ol chain increased markedly while ~ and 3( chain expression increased to a smaller extent. By 5 d after activation, both ~ and/3 chain expression had declined. Although chain expression remained increased compared with resting T cells,/3 chain expression had almost returned to very low baseline levels. In contrast, 3( chain expression appeared to be increased compared with resting T cells and exceeded that of/3 chain. bility, the true number of IL-2 binding sites on resting NK cells may increase from one-to twofold. Nevertheless, these results remain consistent with our flow cytometric results indicating very low levels of expression of both ot and 3, chain in resting NK cells.
Expression of IL-2R Components after Activation of T and NK Cells. We also examined changes in surface expression of the three IL-2R components on PHA-activated T cells (CD3 + cells) and IL-2-activated NK cells (CD56 + cells). As shown in
Discussion
The IL-2R is a complex receptor that includes at least three distinct subunits. Depending on the expression of these subunits, cells can possess receptors with markedly different affinities for IL-2 as well as different functional attributes. The B and 3, chains are members of a large cytokine receptor family characterized by four conserved cysteine residues and a Trp-Ser-X-Trp-Ser (WSXWS) motif in two fibronectin type III modules. Both IL-2RB and IL-2R3, possess large cytoplasmic domains that presumably contribute to signal transduction upon IL-2 binding (13, 14, 18, 40) . In contrast, IL2Rol has a very small cytoplasmic segment and has not been shown to mediate IL-2 internalization or signal transduction by itself. Nevertheless, IL-2Rct appears to facilitate IL-2 delivery to other IL-2R subunits and promotes the formation of high affinity receptors (41) .
Previous studies have demonstrated that the gene encoding the IL-2R3, chain appears to be constitutively transcribed by a variety of lymphoid and myeloid cells. This is compatible with data indicating that the 3, chain gene does not include c/s-acting elements typically associated with inducible expression. Thus, surface expression of the 3, chain is probably regulated posttranscriptionally. However, studies of 3, chain protein expression have heretofore been impeded by a lack of suitable reagents. In the present studies we describe two new Examination of surface expression of IL-2R components in a murine pre-B cell line transfected with different combinations of human cDNA encoding IL-2Rot, IL-2R~, and IL-2R3, confirmed the specificity of the new mAbs. Immune precipitation studies also confirmed the reactivity of these mAbs with a cell surface protein with molecular mass of ",~62-65 kD. It is interesting to note that further analysis of IL-2 binding to these transfectant cell lines demonstrated that neither/8 nor 3, chain bind IL-2 with measurable affinity and that coexpression of these two chains is sufficient to form an intermediate affinity receptor. In the absence of 3, chain, /8 chain clearly interacts with ot chain to form a pseudo-high affinity receptor. In contrast, 3, chain does not appear capable of interacting with ot chain in the absence of/3 chain. In the formation of various IL-2R, these results indicate the 3, chain only interacts with/8, but that/3 chain interacts with both ot and 3,.
Despite the ubiquitous presence of 3, chain message in the hematopoietic cells we examined, cell surface 3, chain was detected primarily on lymphoid cells. We undertook detailed studies of IL-2R subunit expression on T and NK cells because these lymphocytes exhibit distinct functional responses to IL-2. Resting T lymphocytes were found to express very low levels of IL-2R3, chain, whereas both ot and/3 chains were essentially undetectable. After stimulation with PHA, virtually all T cells expressed IL-2Rot at high levels; IL-2R/8 and 3, were more modestly upregulated. Thus, activated T cells appear to express a small number of heterotrimeric high affinity IL-2R that are limited by the number of/8 and 3, chains on the cell surface. The expression of an excess of ot chain appears to promote the formation of high affinity receptors capable of responding to very low concentrations of IL-2. Subsequently, ~ chain expression returns to undetectable levels and the number of or chains also declines, whereas 3, chain expression remains elevated. Since ot and 3, do not appear to interact with each other, the downregulation of expression appears to be an important mechanism for limiting the T cell response to IL-2 in the absence of further stimulation. In this setting, it seems likely that 3, chains that persist after T cell activation are associated with other cytokine receptors, such as IL-4R and IL-7R. In fact, the selective downregulation of B chain may directly promote the interaction of the 3, chain with other cytokine receptors, thus providing a mechanism for directing a sequential response to different cytokines. Similarly, the selective low level expression of 3, chain without either o~ or B on resting T cells may indicate that 3, chain is complexed with receptors for other cytokines before T cell activation.
Resting NK cells incubated with nanomolar concentrations of IL-2 exhibit augmented cytolytic activity and upregulation of cell surface adhesion molecules (4) . These data imply that NK cells constitutively express intermediate affinity IL-2R, and it has been established that virtually all resting NK cells express IL-2R/3 (39, 42) , Although the/3 chain was dearly detected on resting NK cells, our immunofluorescence studies revealed almost no surface staining for the 3" chain. Furthermore, our radiolabeled IL-2 binding studies detected only 'o300 intermediate affinity IL-2R on resting NK cells, which is compatible with the immunofluorescence data. In this regard, normal NK cells resemble the expanded NK cell population in the peripheral blood of cancer patients receiving low dose IL-2 therapy. We found that such expanded NK cells also express IL-2R/3 in excess of IL-2ot and IL-2Ry by immunofluorescence analysis. Voss et al. (43) After in vitro activation, expression of the/3 chain on NK cells remains relatively unchanged whereas both IL-2Rot and IL-2R3" are upregulated. Thus, activated NK cells express a relatively low number of high affinity heterotrimers and intermediate affinity/33' heterodimers together with an excess of presumably nonfunctional/3 chains. With more prolonged culture, ot and 3, chain expression declines to background levels, leaving only/3 chain detectable on the cell surface. In contrast to T cells, we did not find persistent y chain on longterm activated NK cells. The very low expression of 3" chain on either resting or activated NK cells also suggests that these cells would not be responsive to other cytokines that use the 3' chain to facilitate cell surface interactions.
The differences in IL-2R subunit expression by T and NK cells underscore the distinct role of IL-2 in the biology of these lymphocytes. Naive, resting T cells do not express functional IL-2R. After stimulation with antigen or mitogen, T cells secrete IL-2 and express high affinity IL-2R heterotrimers. Furthermore, autocrine stimulation via the IL-2/ IL-2R pathway supports the proliferation and functional differentiation of effector T cells. Upon withdrawal or clearance of antigen, T cells downregulate both IL-2Rc~ and/3 but appear to become unresponsive to exogenous IL-2 primarily because of the marked decrease in expression of/3 chain. In contrast to T cells, resting NK cells express intermediate affinity IL-2R and can respond to IL-2 in the absence of other stimuli. We have demonstrated that resting NK cells constitutively express a very small number of functional/33" heterodimers and a large excess of isolated/3 chains. The isolated/3 chains would only bind IL-2 with extremely low affinity and may not be functional under physiologic conditions. Thus the IL-2 response of resting NK ceils appears to be regulated primarily by the limited expression of both oe and 3' chain.
Despite constitutive expression of 3' chain message by lymphoid cells, we have demonstrated that 3' chain protein expression is tightly and differentially regulated on distinct lymphocyte subsets. It is likely that the precise composition of the IL-2R and of other multi-chain receptors that include the 3' chain will be different on various other hematopoietic cells. In conjunction with mAbs specific for other IL-2R components, mAbs specific for IL-2R3" should be useful reagents to elucidate the biology of complex hematopoietic cytokine receptors.
